It is the first time an advanced therapy for people with moderate RA has been recommended in the UK, and has been welcomed by patients.

Findings using data from the UK CPRD.

All health care providers in the South West of England participated in the study.

No significant effect on viral load vs placebo was observed.

Both psychiatric conditions are common among patients with migraine.

Interim results from the ongoing REACT-1 study.

Analysis of patients from the UK Severe Asthma Registry.

The study showed that WBMRI changed how patients would have been managed in 24 per cent of cases, where clinical data alone would have resulted in surveillance only.

Results from a meta-analysis of RCTs and observational studies.

Treatment resulted in an additional one-year extension of life.

Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine.

COVID-19 Around the world weekly highlights: Biden administration brings change in US, UK vaccinations pass cases...

Findings suggest that outcomes might be improved with targeted physical activity and exercise recommendations.

Findings add to evidence that the syndrome is distinct from Kawasaki disease.